EMA approves fourth Covid-19 vaccine, J&J's single-shot candidate - Pharmaceutical Technology
Janssen Investigational COVID-19 Vaccine Program
AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial | AdventHealth Research Institute
Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19
J&J's Heaton becomes face of COVID-19 booster debate in first months as Janssen vaccine chief | Fierce Biotech
J&J working with Beth Israel to accelerate COVID-19 vaccine developmen
Janssen Vaccine Technologies | Janssen EMEA
Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
COVID-19 Vaccine Could Cost As Little As $10 A Dose, Says Janssen :: Scrip
Medical Countermeasures | USA Public Health Security
Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen's Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC)
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
J&J statement on Janssen vaccine approval | Healthcare Purchasing News
Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Johnson & Johnson Announces European Commission Approval for Janssen's Preventive Ebola Vaccine | Johnson & Johnson
Johnson & Johnson seeks EU approval for its COVID-19 vaccine
